Continued non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists during transcatheter aortic valve implantation
CONCLUSIONS: Continued NOAC compared with continued VKA during TAVI led to comparable outcomes with regard to the composite outcome measure indicating that continued OAC with both drugs is feasible. These hypothesis-generating results need to be confirmed by a dedicated randomised controlled trial.PMID:36440479 | DOI:10.4244/EIJ-D-22-00521
Source: EuroIntervention - Category: Cardiovascular & Thoracic Surgery Authors: Norman Mangner Miriam Brinkert Lukas S Keller Noriaki Moriyama Daniel Hagemeyer Stephan Haussig Lisa Crusius Richard Kobza Mohamed Abdel-Wahab Mika Laine Stefan Stortecky Thomas Pilgrim Fabian Nietlispach Frank Ruschitzka Holger Thiele Stefan Toggweiler A Source Type: research